Strengthening Market Presence: MagPurix 12 N.E.O. Reinforced in Taiwan Through Strategic Partnership
Zinexts and Bio-Check Laboratories are reinforcing their long-standing commitment to Taiwan’s molecular diagnostics community by further expanding the presence of the MagPurix® 12 N.E.O. system in the local market. The collaboration will be highlighted at the Taipei International Instruments Show 2025, taking place from 15–18 October 2025 in Taipei, Taiwan.
Building on years of successful cooperation, Zinexts and Bio-Check Laboratories continue to strengthen their partnership to provide cutting-edge extraction solutions for Taiwan’s research institutes and clinical laboratories.
By combining Zinexts’ Taiwan-based molecular manufacturing expertise with Bio-Check’s well-established distribution and technical support network, the partnership ensures laboratories across Taiwan benefit from reliable access, rapid service response, and sustained local support for advanced molecular workflows.
The MagPurix 12® N.E.O. was developed in response to the growing demand among Taiwan laboratories for high-quality nucleic acid extraction, particularly the preservation of long DNA/RNA fragments, crucial for next-generation sequencing (NGS) and quantitative PCR (qPCR) applications in oncology, infectious diseases, rare disease diagnostics, and beyond.
Through this collaboration, Zinexts reaffirms its dedication to supporting Taiwan’s laboratories in advancing precision medicine with locally supported, high-performance extraction technology.
